Merck Announces $3M Commitment to Address Critical Maternal Health Needs During COVID-19 Pandemic
April 9, 2020 – Merck announced today a commitment to strengthen health systems affected by the COVID-19 pandemic. Through Merck for Mothers, the company’s global initiative to help end preventable maternal deaths, the company will provide $3 million to help health systems better meet the needs of pregnant women before, during and following delivery while tackling COVID-19.
The goal in setting up Merck for Mothers was to advance the quality of maternal health care and improve access to care during one of the most critical moments in a woman’s life. Kenneth C. Frazier, chairman and chief executive officer, Merck reiterated that the “call to action for us is even stronger in the midst of the pandemic. That is why we are increasing our efforts to strengthen the capacity of our health care systems to support these women.”
Dr. Julie L. Gerberding, chief patient officer at Merck also said “Our health systems and heroic health care providers are fully focused on COVID-19, but childbirth will not wait for the pandemic to ease.”
Merck for Mothers will direct investments to efforts in the U.S. and globally in countries impacted by COVID-19 to help address maternal health challenges that are arising as a result of the pandemic. Proposals will be considered on an invitation-only basis.
The $3 million in program funding from Merck for Mothers adds to Merck’s support for global, national and local relief efforts. With this commitment from Merck for Mothers, Merck has contributed or committed more than $11 million to COVID-19 relief efforts thus far. This support has included donations of medicines, protective personal equipment (PPE) donations for health care providers and funding to relief organizations, including the United Nations Foundation’s COVID-19 Solidarity Response Fund in support of the World Health Organization and to the Centers for Disease Control and Prevention (CDC) Foundation Emergency Response Fund.
To learn more about how Merck is responding to the COVID-19 pandemic, please visit www.merck.com.
Read the press release here.
For more than 125 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.
About Merck for Mothers
Merck for Mothers is our company’s $500 million initiative to create a world where no woman has to die giving life. Applying Merck’s business and scientific resources, we collaborate with partners to improve the health and well-being of women during pregnancy, childbirth and the postpartum period. For more information, visit www.merckformothers.com.